.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ALOMIDE Drug Profile

« Back to Dashboard
Alomide is a drug marketed by Alcon and is included in one NDA. It is available from one supplier.

The generic ingredient in ALOMIDE is lodoxamide tromethamine. One supplier is listed for this compound. Additional details are available on the lodoxamide tromethamine profile page.

Summary for Tradename: ALOMIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: ALOMIDE

Clinical Trials for: ALOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
ALOMIDE
lodoxamide tromethamine
SOLUTION/DROPS;OPHTHALMIC020191-001Sep 23, 1993RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ALOMIDE

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon
ALOMIDE
lodoxamide tromethamine
SOLUTION/DROPS;OPHTHALMIC020191-001Sep 23, 19935,457,126<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc